{{Drugbox
| Verifiedfields = 
| Watchedfields = 
| verifiedrevid = 
| IUPAC_name = 2-fluoro-4-[3-(3-fluoro-4-hydroxyphenyl)pentan-2-yl]phenol
| image = Bifluranol.svg
| width = 250

<!--Clinical data-->
| tradename = Prostarex
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = 
| legal_UK = 
| legal_US = 
| legal_status = 
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion =

<!--Identifiers-->
| CAS_number_Ref = 
| CAS_number = 34633-34-6
| CAS_supplemental = 
| ATC_prefix = 
| ATC_suffix = 
| PubChem = 71713
| DrugBank_Ref = 
| DrugBank = 
| ChemSpiderID_Ref = 
| ChemSpiderID = 64763
| ChEMBL = 2105524
| UNII = 47602X79JF

<!--Chemical data-->
| C=17 | H=18 | F=2 | O=2
| molecular_weight = 292.320426 g/mol
| smiles = CCC(C1=CC(=C(C=C1)O)F)C(C)C2=CC(=C(C=C2)O)F
| StdInChI_Ref = 
| StdInChI = 1S/C17H18F2O2/c1-3-13(12-5-7-17(21)15(19)9-12)10(2)11-4-6-16(20)14(18)8-11/h4-10,13,20-21H,3H2,1-2H3
| StdInChIKey_Ref = 
| StdInChIKey = RDVXUHOSYIBGBT-UHFFFAOYSA-N
| synonyms = 
}}

'''Bifluranol''' ([[International Nonproprietary Name|INN]], [[British Approved Name|BAN]]; brand name '''Prostarex'''; former developmental code name '''BX-341''') is a [[nonsteroidal]] [[estrogen]] of the [[stilbestrol]] group related to [[diethylstilbestrol]] that is used as an [[antiandrogen]] in the [[United Kingdom]] in the treatment of [[benign prostatic hyperplasia]].<ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=RA1-PA364|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=152}}</ref><ref name="IndexNominum2000">{{cite book|title=Index Nominum 2000: International Drug Directory|url=https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA124|date=January 2000|publisher=Taylor & Francis|isbn=978-3-88763-075-1|pages=124–}}</ref><ref name="Dekanski1980">{{cite journal | first1=J.B. | last1=Dekanski | title=Anti-prostatic activity of bifluranol, a fluorinated bibenzyl. | journal=British Journal of Pharmacology | year=1980 | volume=71 | issue=1 | pages=11–16 | issn=0007-1188 | doi=10.1111/j.1476-5381.1980.tb10903.x | pmid=6258683 | PMC=2044395}}</ref><ref name="PopeGilbert1981">{{cite journal | first1=D. J. | last1=Pope | title=Bifluranol, a novel fluorinated bibenzyl anti-androgen, its chemistry and disposition in different animal species | last2=Gilbert | first2=A. P. | last3=Easter | first3=D. J. | last4=Chan | first4=R. P. | last5=Turner | first5=J. C. | last6=Gottfried | first6=S. | last7=Parke | first7=D. V. | journal=Journal of Pharmacy and Pharmacology | year=1981 | volume=33 | issue=1 | pages=297–301 | issn=0022-3573 | doi=10.1111/j.2042-7158.1981.tb13784.x | pmid=6116777}}</ref><ref name="BeacockBuck1985">{{cite journal|last1=Beacock|first1=C. J. M.|last2=Buck|first2=A. C.|last3=Roberts|first3=E. E.|title=Bifluranol in the treatment of benign prostatic hyperplasia (BPH)|journal=The Prostate|volume=7|issue=4|year=1985|pages=357–361|issn=0270-4137|doi=10.1002/pros.2990070403}}</ref><ref name="KeaneTimoney1988">{{cite journal | first1=P. F. | last1=Keane | title=Response of the Benign Hypertrophied Prostate to Treatment with an LHRH Analogue | last2=Timoney | first2=A. G. | last3=Kiely | first3=E. | last4=Williams | first4=Gordon | last5=Stamp | first5=G. | journal=British Journal of Urology | year=1988 | volume=62 | issue=2 | pages=163–165 | issn=0007-1331 | doi=10.1111/j.1464-410X.1988.tb04299.x | pmid=2457404}}</ref> It is a poly[[fluorine|fluorinated]] [[biphenyl]] that is related to [[polybrominated biphenyl|polybrominated]] and [[polychlorinated biphenyl]]s and [[diethylstilbestrol]].<ref name="PopeGilbert1981" /><ref name="AgriculturaMejora1978">{{cite book|author1=Spain. Ministerio de Agricultura|author2=Universidad Complutense de Madrid. Departamento de Genetico y Mejora|title=3rd World Congress of Animal Feeding|url=https://books.google.com/books?id=ZgYFAQAAIAAJ|year=1978|publisher=Industrias Gráficas España|isbn=978-84-7391-022-4|page=532}}</ref><ref name="AcademicPress1986">{{cite book|title=Annual Reports in Medicinal Chemistry|url=https://books.google.com/books?id=qsFCGskRHZQC&pg=PA182|date=16 September 1986|publisher=Academic Press|isbn=978-0-08-058365-5|pages=182–}}</ref> The drug is described as a weak estrogen, and possesses about one-eighth the potency of diethylstilbestrol.<ref name="Dekanski1980" /><ref name="AgriculturaMejora1978" /><ref name="Agarwal1987">{{cite book|author=M. K. Agarwal|title=Receptor mediated antisteroid action|url=https://books.google.com/books?id=JfNsAAAAMAAJ|year=1987|publisher=De Gruyter|isbn=978-0-89925-374-9|page=330}}</ref>

In spite of the fact that it is widely referred to as an antiandrogen in the literature, bifluranol is actually a pure estrogen and does not significantly bind to the [[androgen receptor]] or directly [[receptor antagonist|antagonize]] the action of [[androgen]]s.<ref name="Dekanski1980" /> It exerts functional antiandrogen effects by binding to and activating the [[estrogen receptor]] in the [[pituitary gland]], consequently suppressing the secretion of [[luteinizing hormone]] (and hence acting as an [[antigonadotropin]]) and thereby reducing [[gonad]]al androgen production and systemic androgen levels.<ref name="Dekanski1980" /> Bifluranol has also been found to act as a [[CYP17A1|17α-hydroxylase/17,20 lyase]] [[enzyme inhibitor|inhibitor]], though with less [[potency (pharmacology)|potency]] than [[ketoconazole]], and this action may contribute to its efficacy in benign prostatic hyperplasia by further helping to lower androgen levels.<ref name="BarrieRowlands1989">{{cite journal | first1=S.E. | last1=Barrie | title=Inhibition of 17α-hydroxylase/C17-C20 lyase by bifluranol and its analogues | last2=Rowlands | first2=M.G. | last3=Foster | first3=A.B. | last4=Jarman | first4=M. | journal=Journal of Steroid Biochemistry | year=1989 | volume=33 | issue=6 | pages=1191–1195 | issn=0022-4731 | doi=10.1016/0022-4731(89)90429-9 | pmid=2559252}}</ref><ref name="JarmanJohn Smith1998">{{cite journal | first1=Michael | last1=Jarman | title=Inhibitors of enzymes of androgen biosynthesis: cytochrome P450<sub>17α</sub> and 5α-steroid reductase | last2=John Smith | first2=H. | last3=J. Nicholls | first3=Paul | last4=Simons | first4=Claire | journal=Natural Product Reports | year=1998 | volume=15 | issue=5 | pages=495 | issn=0265-0568 | doi=10.1039/a815495y}}</ref><ref name="BarrieHaynes1997">{{cite journal | first1=S.E. | last1=Barrie | title=Biochemistry and pharmacokinetics of potent non-steroidal cytochrome P450<sub>17α</sub> inhibitors | last2=Haynes | first2=B.P. | last3=Potter | first3=G.A. | last4=Chan | first4=F.C.Y. | last5=Goddard | first5=P.M. | last6=Dowsett | first6=M. | last7=Jarman | first7=M. | journal=The Journal of Steroid Biochemistry and Molecular Biology | year=1997 | volume=60 | issue=5-6 | pages=347–351 | issn=0960-0760 | doi=10.1016/S0960-0760(96)00225-7}}</ref>

Related drugs include [[pentafluranol]] (BX-430) and [[terfluranol]] (BX-428), which are also estrogens.<ref name="Polonii1984">{{cite book|author=Polska Akademia Nauk. Komitet Badania Polonii|title=II Kongres Uczonych Polskiego Pochodzenia: zbiór materiałów|url=https://books.google.com/books?id=_-VjAAAAIAAJ|year=1984|publisher=Zakład Narodowy im. Ossolińskich|isbn=978-83-04-01670-5|quote=[This explains why the estrogenic activity is minimal in terms of pentafluranol or even bifluranol. Doses which shall apply from 1 to 6 days of pregnancy, are in micrograms per kg of body weight: bifluranol 80, 30 and terfluranol pentafluranol 280 ...]}}</ref>

==See also==
* [[Acefluranol]]
* [[Paroxypropione]]
* [[Metallibure]]

==References==
{{Reflist|30em}}

{{Estrogens and antiestrogens}}
{{Androgens and antiandrogens}}
{{Estrogen receptor modulators}}

[[Category:Antigonadotropins]]
[[Category:Biphenyls]]
[[Category:CYP17A1 inhibitors]]
[[Category:Enzyme inhibitors]]
[[Category:Fluoroarenes]]
[[Category:Synthetic estrogens]]


{{antineoplastic-drug-stub}}
{{genito-urinary-drug-stub}}